1[1]Zwaka TP,Hombach V,Torzewski J.C-reactive protein mediated low density lipoprotein uptake by macrophages:implications for atherosclerosis[J].Circulation,2001,103(9):1194-1197.
2[2]Yeh ET,Anderson HV,Pasceri V,et al.C-reactive protein linking inflammation to cardiovascular complications[J].Circulation,2001,104(9):974-975.
3[3]Whitehead AS,Bruns GA,Markham AF,et al.Isolation of human C-reactive protein complementary DNA and localization of the gene to chromosome 1[J].Science,1983,221(4605):69-71.
4[4]Ridker PM,Stampfer MJ,Rifai N.Novel risk factors for systemic atherosclerosis:a comparison of C-reactive protein,fibrinogen,homocysteine lipoprotein(a),and standard cholesterol screening predictors of peripheral arterial disease[J].JAMA,2001,285(19):2481-2485.
5[5]Shrive AK,Cheetham GM,Holden D,et al.Three dimensional structure of human C-reactive protein[J].Nature Struct Biol,1996,3(4):346-354.
6[6]Roberts WL,Moulton L,Law TC,et al.Evaluation of nine automated high-sensitivity C-reactive protein methods:implications for clinical and epidemiological applications.Part 2[J].Clin Chem,2001,47(3):418-425.
7[7]Ridker PM,Rifai N,Rose L,et al.Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events[J].N Engl J Med,2002,347(20):1557-1565.
8[8]Rifai N,Ridker PM.Population distributions of C-reactive protein apparently healthy men and women in the United States:implication for clinical interpretation[J].Clin Chem,2003,49(4):666-669.
9[9]Verma S,Wang CH,Li SH,et al.A self-fulfilling prophecy:C-reactive protein attenuates nitric oxide production and inhibits angiogenesis[J].Circulation,2002,106(8):913-919.
10[10]Verma S,Li SH,Badiwala MV,et al.Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein[J].Circulation,2002,105(16):1890-1896.
7Luft FC. More reactive and less reactive C-reactive protein. J Mol Med (Berl) ,2005,83:411-412.
8Roberts WL, Scbwarz EI., Ayanian S, et aI. Performance characteristics of a point of care C reactive protein assay. Clin Chim Acta, 2001,314:255-259.
9Almirall J, Boliloar I, Toran P, et al. Contribution of C reactive protein to the diagnosis and assessment of severity of community acquired pneumonia. Chest, 2004, 125: 1335- 1342.
10Dahl M, Vestbo J, Zacho J, et al. C reactive protein and chronic obstructive pulmonary disease : a Mendelian randomisation approach. Thorax, 2011,66 :197-204.
